Block Robert, Corsetti James, Goldenberg Ilan, Vorobiof Gabriel, McNitt Scott, Ryan Daniel, Zareba Wojciech, Moss Arthur J
Department of Community and Preventive Medicine, University of Rochester, Rochester, NY;
Heart Int. 2009 Jun 30;4(1):e8. doi: 10.4081/hi.2009.e8.
Since data regarding the relationship between a common polymorphism (SNP) of the apoA1 gene with apoA1 levels and risk of coronary artery disease are inconsistent, we hypothesized that its association with recurrent coronary events differs for White and Black individuals with diagnosed coronary heart disease. The apoA1 -75G>A SNP was genotyped in a cohort of 834 Black (n=129) and White (n=705) post-myocardial infarction patients. Recurrent coronary events (coronary-related death, non-fatal myocardial infarction, or unstable angina) were documented during an average follow-up of 28 months. Thirty percent of White and 21% of Black patients carried the SNP. Cox proportional-hazards regression analysis, adjusting for clinical and laboratory covariates, demonstrated that the SNP was not associated with recurrent events in the total cohort (HR=1.37, 95% CI 0.95-1.97; p= 0.09) but was the only variable associated with an increased risk of recurrent cardiac events in Blacks (HR=2.40, 95% CI 1.07-5.40; p= 0.034). Conversely in Whites, the SNP was not associated with recurrent events (HR=1.12, 95% CI 0.75-1.67; p= 0.59) whereas apoB (HR=1.78, 95% CI 1.20 -2.65; p= 0.0042) and calcium channel blocker use (HR=2.53, 95% CI 1.72-3.72; p<0.001) were associated; p= 0.0024 for interaction between ethnicity and the SNP. A common apoA1 SNP is associated with a significantly increased risk of recurrent cardiac events among Black, but not White, postmyocardial infarction patients. Relationships with lipoproteins may help explain this finding.
由于载脂蛋白A1(apoA1)基因常见多态性(单核苷酸多态性,SNP)与apoA1水平及冠状动脉疾病风险之间的关系数据并不一致,我们推测,对于已确诊冠心病的白人和黑人个体,该多态性与复发性冠状动脉事件的关联存在差异。我们对834名心肌梗死后的患者(其中黑人129名,白人705名)进行了apoA1 -75G>A SNP基因分型。在平均28个月的随访期内,记录复发性冠状动脉事件(与冠状动脉相关的死亡、非致命性心肌梗死或不稳定型心绞痛)。30%的白人患者和21%的黑人患者携带该SNP。在对临床和实验室协变量进行校正后,Cox比例风险回归分析表明,该SNP与整个队列中的复发性事件无关(风险比[HR]=1.37,95%置信区间[CI] 0.95 - 1.97;p = 0.09),但却是与黑人复发性心脏事件风险增加相关的唯一变量(HR=2.40,95% CI 1.07 - 5.40;p = 0.034)。相反,在白人中,该SNP与复发性事件无关(HR=1.12,95% CI 0.75 - 1.67;p = 0.59),而载脂蛋白B(HR=1.78,95% CI 1.20 - 2.65;p = 0.0042)和使用钙通道阻滞剂(HR=2.53,95% CI 1.72 - 3.72;p<0.001)与之相关;种族与该SNP之间的交互作用p = 0.0024。在心肌梗死后的患者中,常见的apoA1 SNP与黑人而非白人复发性心脏事件风险的显著增加相关。与脂蛋白的关系可能有助于解释这一发现。